NDC 70771-1622-3
Emtricitabine and tenofovir disoproxil fumarate 167 mg/1
Emtricitabine and tenofovir disoproxil fumarate · TABLET, FILM COATED
Emtricitabine and tenofovir disoproxil fumarate is a combination medication taken by mouth to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called nucleoside analog reverse transcriptase inhibitors, which work by slowing the replication of HIV in the body.
Key Facts
- Brand Name
- Emtricitabine and tenofovir disoproxil fumarate
- Generic Name
- Emtricitabine and tenofovir disoproxil fumarate
- NDC Code (Package)
70771-1622-3- NDC Code (Product)
70771-1622- Manufacturer
- Zydus Lifesciences Limited
- Strength
- 167 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA212689
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 07/01/2021
Recall History
No Recall HistoryView Full Drug Page
Emtricitabine and tenofovir disoproxil fumarate — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.